Thierry Facon


Ontology type: schema:Person     


Person Info

NAME

Thierry

SURNAME

Facon

Publications in SciGraph latest 50 shown

  • 2018-07 Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network in LEUKEMIA
  • 2018-06 A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial in LEUKEMIA
  • 2018-06 Targeting MYC in multiple myeloma in LEUKEMIA
  • 2018-06 Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents in LEUKEMIA
  • 2018-05 Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma in ANNALS OF HEMATOLOGY
  • 2018 Treatment of Elderly Patients with Multiple Myeloma in MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS
  • 2017-12-18 Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network in LEUKEMIA
  • 2017-12-06 Targeting MYC in multiple myeloma in LEUKEMIA
  • 2017-12 Logic programming reveals alteration of key transcription factors in multiple myeloma in SCIENTIFIC REPORTS
  • 2017-11 Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial in LEUKEMIA
  • 2017-06 Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR in LEUKEMIA
  • 2017-01 Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study in LEUKEMIA
  • 2016-06 Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma in DRUGS
  • 2016-05 Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma in DRUGS
  • 2016 Treatment of Newly Diagnosed Elderly Multiple Myeloma in PLASMA CELL DYSCRASIAS
  • 2016-01 Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial in BLOOD CANCER JOURNAL
  • 2015 Treatment of elderly patients with myeloma in HANDBOOK OF MULTIPLE MYELOMA
  • 2014-12 Heterogeneity of genomic evolution and mutational profiles in multiple myeloma in NATURE COMMUNICATIONS
  • 2014-08 Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma in LEUKEMIA
  • 2014-03 Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients in LEUKEMIA
  • 2013-12 Memory loss during lenalidomide treatment: a report on two cases in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-11 Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma in LEUKEMIA
  • 2013-02 Minor clone provides a reservoir for relapse in multiple myeloma in LEUKEMIA
  • 2012-12 Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma in CLINICAL PHARMACOKINETICS
  • 2012-12 Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimens in LEUKEMIA
  • 2011-09 Renouveau des traitements d’entretien dans le myélome multiple : place des immunomodulateurs (IMiDs) in ONCOLOGIE
  • 2011-05 Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma in LEUKEMIA
  • 2011-03-19 Firstline Treatment and Maintenance in Newly Diagnosed Multiple Myeloma Patients in MULTIPLE MYELOMA
  • 2010-08 Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma in ANNALS OF HEMATOLOGY
  • 2010-07 Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy in LEUKEMIA
  • 2010-06 Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial in LEUKEMIA
  • 2008-04 Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study in LEUKEMIA
  • 2007-09 Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials in LEUKEMIA
  • 2007-01 Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials in LEUKEMIA
  • 2006-10 Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens in ANNALS OF HEMATOLOGY
  • 2006-06 Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP) in LEUKEMIA
  • 2006-05 Traitement du myélome multiple in ONCOLOGIE
  • 2005-11 Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML in LEUKEMIA
  • 2005-01 Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma in ANNALS OF HEMATOLOGY
  • 2005-01 Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC) in BONE MARROW TRANSPLANTATION
  • 2003 Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients in MONOCLONAL GAMMOPATHIES AND THE KIDNEY
  • 2002 Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM). in HAEMATOLOGICA
  • 1999-08 Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 1999-05 Induction of apoptosis by all-trans retinoic acid in the human myeloma cell line RPMI 8226 and negative regulation of some of its typical morphological features by dexamethasone in CELL DEATH & DIFFERENTIATION
  • 1999-04 Evaluation of minimal residual disease by interphase FISH in multiple myeloma: does complete remission exist? in LEUKEMIA
  • 1999-03 Lack of efficacy of clarithromycin in advanced multiple myeloma in LEUKEMIA
  • 1999-02 Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two cases in LEUKEMIA
  • 1998-02 Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells in LEUKEMIA
  • 1993-01 Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma in JOURNAL OF CLINICAL IMMUNOLOGY
  • 1991-08 Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: A report on 33 patients in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.413875.c", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4461.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411167.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.31151.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4817.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.139510.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411766.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.277151.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.189967.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5253.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410529.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412220.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413744.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412370.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411154.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411162.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411147.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.42399.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411394.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411777.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410463.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418189.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410527.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413780.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477015.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419849.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414282.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.25879.31", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418453.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411149.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416091.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417812.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418443.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412180.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415224.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7942.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418596.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411175.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17788.31", 
            "type": "Organization"
          }
        ], 
        "familyName": "Facon", 
        "givenName": "Thierry", 
        "id": "sg:person.01125032152.62", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0001-7705-8460"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62", 
          "https://orcid.org/0000-0001-7705-8460"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:16", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_936.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01125032152.62'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01125032152.62'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01125032152.62'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01125032152.62'


     

    This table displays all metadata directly associated to this object as RDF triples.

    109 TRIPLES      11 PREDICATES      57 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01125032152.62 schema:affiliation N01d14eb5538144308f8ee89210851ab7
    2 https://www.grid.ac/institutes/grid.139510.f
    3 https://www.grid.ac/institutes/grid.17788.31
    4 https://www.grid.ac/institutes/grid.189967.8
    5 https://www.grid.ac/institutes/grid.240614.5
    6 https://www.grid.ac/institutes/grid.25879.31
    7 https://www.grid.ac/institutes/grid.277151.7
    8 https://www.grid.ac/institutes/grid.31151.37
    9 https://www.grid.ac/institutes/grid.38142.3c
    10 https://www.grid.ac/institutes/grid.410463.4
    11 https://www.grid.ac/institutes/grid.410527.5
    12 https://www.grid.ac/institutes/grid.410529.b
    13 https://www.grid.ac/institutes/grid.411147.6
    14 https://www.grid.ac/institutes/grid.411149.8
    15 https://www.grid.ac/institutes/grid.411154.4
    16 https://www.grid.ac/institutes/grid.411162.1
    17 https://www.grid.ac/institutes/grid.411167.4
    18 https://www.grid.ac/institutes/grid.411175.7
    19 https://www.grid.ac/institutes/grid.411394.a
    20 https://www.grid.ac/institutes/grid.411766.3
    21 https://www.grid.ac/institutes/grid.411777.3
    22 https://www.grid.ac/institutes/grid.412180.e
    23 https://www.grid.ac/institutes/grid.412220.7
    24 https://www.grid.ac/institutes/grid.412370.3
    25 https://www.grid.ac/institutes/grid.413734.6
    26 https://www.grid.ac/institutes/grid.413744.1
    27 https://www.grid.ac/institutes/grid.413780.9
    28 https://www.grid.ac/institutes/grid.414282.9
    29 https://www.grid.ac/institutes/grid.415224.4
    30 https://www.grid.ac/institutes/grid.416091.b
    31 https://www.grid.ac/institutes/grid.417812.9
    32 https://www.grid.ac/institutes/grid.418189.d
    33 https://www.grid.ac/institutes/grid.418443.e
    34 https://www.grid.ac/institutes/grid.418453.f
    35 https://www.grid.ac/institutes/grid.418596.7
    36 https://www.grid.ac/institutes/grid.419849.9
    37 https://www.grid.ac/institutes/grid.42399.35
    38 https://www.grid.ac/institutes/grid.4461.7
    39 https://www.grid.ac/institutes/grid.477015.0
    40 https://www.grid.ac/institutes/grid.4817.a
    41 https://www.grid.ac/institutes/grid.5253.1
    42 https://www.grid.ac/institutes/grid.5645.2
    43 https://www.grid.ac/institutes/grid.65499.37
    44 https://www.grid.ac/institutes/grid.7429.8
    45 https://www.grid.ac/institutes/grid.7942.8
    46 schema:familyName Facon
    47 schema:givenName Thierry
    48 schema:identifier N141d664b847946e187cb9b4c53690786
    49 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62
    50 https://orcid.org/0000-0001-7705-8460
    51 schema:sdDatePublished 2019-03-07T15:16
    52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    53 schema:sdPublisher N14ed203da0ae4cb8a0be2d4196e7d974
    54 sgo:license sg:explorer/license/
    55 sgo:sdDataset persons
    56 rdf:type schema:Person
    57 N01d14eb5538144308f8ee89210851ab7 schema:affiliation https://www.grid.ac/institutes/grid.413875.c
    58 sgo:isCurrent true
    59 rdf:type schema:OrganizationRole
    60 N141d664b847946e187cb9b4c53690786 schema:name orcid_id
    61 schema:value 0000-0001-7705-8460
    62 rdf:type schema:PropertyValue
    63 N14ed203da0ae4cb8a0be2d4196e7d974 schema:name Springer Nature - SN SciGraph project
    64 rdf:type schema:Organization
    65 https://www.grid.ac/institutes/grid.139510.f schema:Organization
    66 https://www.grid.ac/institutes/grid.17788.31 schema:Organization
    67 https://www.grid.ac/institutes/grid.189967.8 schema:Organization
    68 https://www.grid.ac/institutes/grid.240614.5 schema:Organization
    69 https://www.grid.ac/institutes/grid.25879.31 schema:Organization
    70 https://www.grid.ac/institutes/grid.277151.7 schema:Organization
    71 https://www.grid.ac/institutes/grid.31151.37 schema:Organization
    72 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    73 https://www.grid.ac/institutes/grid.410463.4 schema:Organization
    74 https://www.grid.ac/institutes/grid.410527.5 schema:Organization
    75 https://www.grid.ac/institutes/grid.410529.b schema:Organization
    76 https://www.grid.ac/institutes/grid.411147.6 schema:Organization
    77 https://www.grid.ac/institutes/grid.411149.8 schema:Organization
    78 https://www.grid.ac/institutes/grid.411154.4 schema:Organization
    79 https://www.grid.ac/institutes/grid.411162.1 schema:Organization
    80 https://www.grid.ac/institutes/grid.411167.4 schema:Organization
    81 https://www.grid.ac/institutes/grid.411175.7 schema:Organization
    82 https://www.grid.ac/institutes/grid.411394.a schema:Organization
    83 https://www.grid.ac/institutes/grid.411766.3 schema:Organization
    84 https://www.grid.ac/institutes/grid.411777.3 schema:Organization
    85 https://www.grid.ac/institutes/grid.412180.e schema:Organization
    86 https://www.grid.ac/institutes/grid.412220.7 schema:Organization
    87 https://www.grid.ac/institutes/grid.412370.3 schema:Organization
    88 https://www.grid.ac/institutes/grid.413734.6 schema:Organization
    89 https://www.grid.ac/institutes/grid.413744.1 schema:Organization
    90 https://www.grid.ac/institutes/grid.413780.9 schema:Organization
    91 https://www.grid.ac/institutes/grid.413875.c schema:Organization
    92 https://www.grid.ac/institutes/grid.414282.9 schema:Organization
    93 https://www.grid.ac/institutes/grid.415224.4 schema:Organization
    94 https://www.grid.ac/institutes/grid.416091.b schema:Organization
    95 https://www.grid.ac/institutes/grid.417812.9 schema:Organization
    96 https://www.grid.ac/institutes/grid.418189.d schema:Organization
    97 https://www.grid.ac/institutes/grid.418443.e schema:Organization
    98 https://www.grid.ac/institutes/grid.418453.f schema:Organization
    99 https://www.grid.ac/institutes/grid.418596.7 schema:Organization
    100 https://www.grid.ac/institutes/grid.419849.9 schema:Organization
    101 https://www.grid.ac/institutes/grid.42399.35 schema:Organization
    102 https://www.grid.ac/institutes/grid.4461.7 schema:Organization
    103 https://www.grid.ac/institutes/grid.477015.0 schema:Organization
    104 https://www.grid.ac/institutes/grid.4817.a schema:Organization
    105 https://www.grid.ac/institutes/grid.5253.1 schema:Organization
    106 https://www.grid.ac/institutes/grid.5645.2 schema:Organization
    107 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
    108 https://www.grid.ac/institutes/grid.7429.8 schema:Organization
    109 https://www.grid.ac/institutes/grid.7942.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...